Mycobacterium arupense pulmonary infection: Antibiotic resistance and restriction fragment length polymorphism analysis

Neonakis, I. K.; Gitti, Z.; Kontos, F.; Baritaki, S.; Petinaki, E.; Baritaki, M.; Liakou, V.; Zerva, L.; Spandidos, D. A.
April 2010
Indian Journal of Medical Microbiology;Apr2010, Vol. 28 Issue 2, p173
Academic Journal
Mycobacterium arupense is a novel mycobacterium species. It was first identified from clinical specimens in 2006 and since then there have been only two reports of its recovery from clinical samples. In the present case M. arupense was isolated from the sputum of a 62-year-old man with a malignant mass in his left kidney, who presented with a one-month history of recurrent fever, dyspnea and haemoptysis. M. arupense was identified with sequencing of hsp65 and 16S rRNA genes. In the present study, its biochemical profile along with its resistance status and hsp65 RFLP analysis is presented.


Related Articles

  • Reversible restrictive lung disease stimulating asthma. Hudgel, David W.; Cooper, David; Souhrada, Joseph; Hudgel, D W; Cooper, D; Souhrada, J // Annals of Internal Medicine;Sep76, Vol. 85 Issue 3, p328 

    A young adult woman presented with spontaneous and exercise-induced episodic dyspnea without wheezing. During dyspneic episodes all static lung volumes decreased markedly, the inspiratory capacity fell from 3.0 to 1.1 litres and total lung capacity from 5.3 to 2.6 litres. Airway resistance (Raw)...

  • Efficacy and Safety of a New Immunostimulating Bacterial Lysate in the Prophylaxis of Acute Lower Respiratory Tract Infections. Rossi, Sandro; Tazza, Roberto // Drug Research / Arzneimittel-Forschung (Editio Cantor Verlag fur;Jan2004, Vol. 54 Issue 1, p50 

    The aim of the present trial was the assessment of the efficacy and safety of a treatment with Ismigen®, a new immuno-stimulating lysate prepared by bacteria mechanical lysis (MLBL), in the prophylaxis of lower respiratory tract infections (LRTIs) in adults, in comparison to a treatment with...

  • B-Type Natriuretic Peptide for Evaluation of Acute Dyspnea. Zepf, Bill // American Family Physician;11/1/2004, Vol. 70 Issue 9, p1796 

    Discusses research being done on the use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. Reference to a study by C. Mueller et al published in the February 12, 2004 issue of the "New England Journal of Medicine"; Findings of the study; Conclusion of the study.

  • Heart failure following left-sided pneumonectomy in a patient with known pectus excavatum — successful treatment using the Ravitch procedure Welter, Stefan; Hinterthaner, Marc; Stamatis, Georgios // European Journal of Cardio-Thoracic Surgery;Apr2006, Vol. 29 Issue 4, p630 

    Abstract: A rare case of a patient with progressive dyspnoea due to atrial compression between ascending and descending aorta is demonstrated. After neoadjuvant chemoradiation for a locally advanced nonsmall cell lung cancer stage IIIb, he had a left-sided pneumonectomy. The underlying problem...

  • Unexplained dyspnea in an old patient with recurrent stroke: platypnea–orthodeoxia syndrome and evidence of patent foramen ovale. Angelini, Monica; Lambru, Giorgio; Montepietra, Sara; Riccardi, Massimo; Zanferrari, Carla; Bortone, Ermelinda // Neurological Sciences;Feb2010, Vol. 31 Issue 1, p93 

    Platypnea–orthodeoxia is a syndrome characterized by dyspnea and hypoxemia in orthostatism relieved by supine position. This phenomenon is frequently associated with interatrial communication, mainly patent foramen ovale. The association of platypnea–orthodeoxia syndrome with...

  • 71-Year-Old Man With Shortness of Breath and Rash. Maripuri, Saugar; Fervenza, Fernando C. // Mayo Clinic Proceedings;Dec2008, Vol. 83 Issue 12, p1388 

    The article presents a medical case of a 71-year-old man with idiopathic pulmonary fibrosis who was transferred in an institution for evaluation of worsening dyspnea, fatigue, and rash. The patient has been admitted in a local hospital but was transferred to another institution due to the...

  • A clinical and biochemical score for mortality prediction in patients with acute dyspnoea: derivation, validation and incorporation into a bedside programme. Baggish, A. L.; Lloyd-Jones, U. M.; Blatt, J.; Richards, A. M.; Lainchbury, J.; O'Donoghue, M.; Sakhuja, R.; Chen, A. A.; Januzzi, J. L. // Heart;Aug2008, Vol. 94 Issue 8, p1032 

    Background: Risk stratification for patients with acute dyspnoea is a challenging task. No quantitative tool for mortality prediction among patients with acute dyspnoea is available. Methods: 595 dyspnoeic subjects were enrolled in an emergency department. Clinical and biochemical factors...

  • Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD. Jensen, D.; Amjadi, K.; Harris-McAllister, V.; Webb, K. A.; O'Donnell, D. E. // Thorax;Jul2008, Vol. 63 Issue 7, p606 

    Background: This study examined the effects of inhaled furosemide on the ventilatory and perceptual response to high-intensity constant-load cycle exercise in chronic obstructive pulmonary disease (COPD). Methods: In a randomised, double-blind, placebo-controlled, crossover study, 20 patients...

  • The simultaneous occurrence of deep vein thrombosis and pulmonary and arterial embolization. Dixon, Teabra; Panda, Mukta; Desbiens, Norman // JGIM: Journal of General Internal Medicine;Jul2007, Vol. 22 Issue 7, p1040 

    Introduction: A 45-year-old female presented with 8 hours of right lower extremity pain and dyspnea. She was tachycardic and her right lower extremity was dusky, cold, and pulseless. Discussion: Computerized tomography of the venous and arterial systems revealed massive...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics